Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.
Acta Neurol Belg. 2011 Jun;111(2):89-98.
Magnetic resonance imaging (MRI) has become an established tool to diagnose multiple sclerosis (MS) and to monitor its evolution. In patients at presentation with clinically isolated syndromes suggestive of MS, MRI criteria for MS diagnosis have been proposed and are updated on a regular basis. In addition, MRI "red flags" useful for the differential diagnosis from other neurological conditions which can mimic MS have been identified. In patients with established MS, the ability of MR measures in explaining patients' clinical status and progression of disability is still suboptimal. This has prompted the extensive application of modern MR-based technologies to estimate the overall disease burden in patients at different stages of the disease. The use of these techniques has allowed to grade in vivo the heterogeneity of MS pathology not only in focal lesions, but also in the normal-appearing white matter and grey matter. Combined with the use of functional MRI, this is ameliorating progressively our understanding of the factors associated to MS evolution. This review summarizes how MRI has improved our ability to diagnose MS and to predict its course, as well as how it is changing our understanding of the factors associated with the accumulation of irreversible disability in this condition.
磁共振成像(MRI)已成为诊断多发性硬化症(MS)和监测其演变的既定工具。在出现提示 MS 的临床孤立综合征的患者中,已经提出了 MS 诊断的 MRI 标准,并定期进行更新。此外,还确定了有助于与其他可能模仿 MS 的神经系统疾病进行鉴别诊断的 MRI“危险信号”。在已确诊的 MS 患者中,MR 测量在解释患者的临床状况和残疾进展方面的能力仍然欠佳。这促使广泛应用现代基于 MRI 的技术来评估不同疾病阶段患者的整体疾病负担。这些技术的使用不仅可以在局灶性病变中,而且可以在正常表现的白质和灰质中,对 MS 病理学的异质性进行体内分级。结合功能 MRI 的使用,这正在逐步改善我们对与 MS 演变相关因素的理解。这篇综述总结了 MRI 如何提高我们诊断 MS 和预测其病程的能力,以及它如何改变我们对与这种情况下不可逆转残疾累积相关因素的理解。